Chemoembolization, Therapeutic clinical trials at UCSD

• Contrast-enhanced Ultrasound Evaluation of Chemoembolization

  open to eligible people ages 21 years and up

  The primary objective of this trial is to evaluate the sensitivity and specificity of 2D and 4D contrast enhanced ultrasound for monitoring transarterial chemoembolization (TACE) response 1-2 weeks and 1 month post treatment as an alternative to contrast-enhanced magnetic resonance (MRI) or computed tomography (CT) imaging

  La Jolla, California and other locations

Last updated: August 31, 2021